Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, and SD Biosensor, Inc. (“SDB”) (KOSE: A137310) and SJL Partners LLC (“SJL”) (collectively, the “Consortium”), announced Tuesday that they have completed the transaction to acquire Meridian. Under the terms of the merger, Meridian shareholders have the right to receive $34.00 per share in cash. Meridian stock will no longer be traded on the NASDAQ Global Select Market. Meridian will continue to operate as an independent entity, under new ownership, headquartered in Cincinnati, Ohio.
Read the full article: SD Biosensor and SJL Partners Complete Transaction to Acquire Meridian Bioscience //
Source: https://www.prnewswire.com/news-releases/sd-biosensor-and-sjl-partners-complete-transaction-to-acquire-meridian-bioscience-301735165.html